Bedtime dosing works well because sleep represents a natural fasted state
"This has been shown in studies, often [with] fewer side effects." More oral GLP-1s may be coming in 2026, according to Decotiis, including an Orforglipron application by Lilly and a new combination Novo Nordisk drug, which is pending approval later next year
Abnormal MCH levels can indicate anemia or other blood-related disorders
: - , , If you are using GLP-1 to control or reduce weight, the rules have changed
Conversely, if your markers suggest a new issue, they can initiate the necessary clinical investigations
Conversely, maintaining consistent meal timing, adequate hydration, and soluble fiber intake significantly reduces gallstone incidence